FOLH1 and neoplasm: PSMA imaging is recommended for assessing the PSMA expression of the tumor and its metastases is considered essential in determining the suitability of a patient for PSMA therapy (and also for commencement of further cycles), and is also valuable for, among other things, assessing tumor response rather relying on a simple serum blood marker.